Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
4 hedge funds and large institutions have $14K invested in Motif Bio plc Warrants to Purchase ADRs in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
68% less capital invested
Capital invested by funds: $44K → $14K (-$30K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$266 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $12K | – | – | – |
|
|
SGCM
2
Sand Grove Capital Management
London,
United Kingdom
| $2K | – | – | – |
|
|
WAM
3
Wolverine Asset Management
Chicago,
Illinois
| – | -$266 | -3,364 | -16% |
|
MTFBW Hedge Fund Activity: Q3 2019 in Review
4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q3 2019, worth a combined $14K — down 68% from $44K a quarter earlier.
Fund positioning in MTFBW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Wolverine Asset Management, cutting an estimated $266.
- 4 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $14K of Motif Bio plc Warrants to Purchase ADRs stock for Q3 2019, down 68% quarter-over-quarter.
- 0 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q3 2019 and 0 closed out.
- The largest Motif Bio plc Warrants to Purchase ADRs seller in Q3 2019 was Wolverine Asset Management, an estimated $266 sold.
Based on aggregated 13F filings for Q3 2019.